NASDAQ:ZYME | Free Cash Flow | Zymeworks Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$45.72M$216,000.00-$45.93M
2025-12-31-$10.26M$581,000.00-$10.84M
2025-03-31-$3.41M$16,000.00-$3.42M
2024-12-31-$41.51M$314,000.00-$41.82M
2024-03-31-$37.68M$185,000.00-$37.86M
2023-12-31$13.93M$356,000.00$13.58M
2023-03-31-$83.19M$386,000.00-$83.58M
2022-12-31$327.36M$348,000.00$327.01M105.68%
2022-03-31-$55.41M$4.16M-$59.57M
2021-12-31-$50.51M$4.78M-$55.29M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$33.01M$1.52M-$34.53M
2024-12-31-$110.06M$1.99M-$112.05M
2023-12-31-$118.32M$2.47M-$120.8M
2022-12-31$144.11M$8.15M$135.96M109.34%
2021-12-31-$192.45M$12.4M-$204.86M
2020-12-31-$151.4M$4.31M-$155.71M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.